Minimal Residual Disease in Multiple Myeloma: Foundations and Clinical Relevance
The SPCC (Sharing Progress in Cancer Care) webinar, titled "MRD in multiple myeloma: foundations and clinical relevance," is a high-level educational session scheduled for February 11, 2026. As Minimal Residual Disease (MRD) transitions from a clinical trial endpoint to a critical tool for personalized oncology, this webinar aims to bridge the gap between scientific theory […]